344 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
30 May 24
Other Events
4:03pm
of $75 million. The closing was subject to the satisfaction of customary closing conditions, including execution of customary ancillary documents
8-K
EX-10.1
z1bwpky2rq7jr
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-10.1
npzfiiu5fdiohn7u2t
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
hmetmr j7zr7cxm
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
u3a3im9wds8cq
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
S-3ASR
EX-4.3
c1xkmv
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-1.2
681udrxt7a hn1nu
30 Sep 22
Automatic shelf registration
4:17pm
S-8
EX-10.2
5prt8 os0y4uaxk
13 Jun 22
Registration of securities for employees
8:44am